Aromatase inhibitors (AIs), such as Arimidex, Aromasin, and Femara, have proven to be more effective than previous hormonal treatments for treating both early and advanced breast cancer in post-menopausal women whose tumors are dependent on estrogen. Compared with tamoxifen, these drugs are less likely to cause blood clots or raise the risk of endometrial cancer. As a result, AIs are used both in patients with early breast cancer and in those with metastatic disease.
It was glitter and glue when patients, visitors, and Dana-Farber staff gathered on Oct. 4 to create art on an unusual canvas – bras. Hosted by Friends’ Place and Dana-Farber’s Creative Arts Program, the “Decorate a Brassiere” art therapy event allowed attendees to creatively honor Breast Cancer Awareness Month.
This Sunday, 7,000 runners will step up to the starting line for the 12th annual Boston Athletic Association (BAA) Half Marathon presented by Dana-Farber and the Jimmy Fund. 500 of them will run not only to set a personal record on the 13.1-mile course, but also to raise money for Dana-Farber. Included in that group are a number of runners we’re happy to call our colleagues. Here are two of their stories.
Steven Clifford is an 18-year-old osteosarcoma survivor. A Boston native, he starts college at the University of California, San Diego this month. This is his story. Life is made up of many difficult decisions. However, imagine my surprise when I had to make a tough and potentially life changing decision at the young age of 11. Up until then, I just was an average child who couldn’t wait to get out of school to play any sport imaginable with his friends.
By Lola Baltzell People often ask me: How do you manage to live with metastatic breast cancer? One of the most important strategies for me has been building a support network. My diagnosis of breast cancer that had already spread to my bones came out of the blue. I had a normal mammogram 13 months earlier, and no known risk factors. So when I heard the news in August 2008, my first impulse was to reach out for support.
In 2012, it is estimated that more than 22,000 new cases of ovarian cancer will be found, and over 15,000 women will die from the disease, according to the National Cancer Institute. Unfortunately, in many cases the cancer isn’t detected until it is advanced. It’s important to recognize the symptoms and urge the women in your life to take early action.
Faces of Childhood Cancer: Sarah Levin Sarah Levin is 11 years old, and has beaten acute lymphoblastic leukemia (ALL) twice. This is her story. The first time I got diagnosed with ALL I was only three, so I don’t remember that much about it. But what my mom and dad have told me is that it was a really sad and scary time for my family.
September is Ovarian Cancer Awareness Month and in recognition of that, we asked ovarian cancer survivor Margaret Winchester to share her story. After being diagnosed with advanced (stage IIIC) ovarian cancer in 2008, I chose Dana-Farber for my care because I knew about the Institute’s cutting-edge approach to cancer care and research.